Photo taken on Nov. 6, 2015 shows a view of the refurbished parliamentary office in Accra, capital of Ghana. China'S State Hualong Construction Ghana Limited handed over here on Friday the completed refurbished office structure to Ghana's parliament. (Xinhua/Lin Xiaowei)
Photo taken on Nov. 6, 2015 shows a view of the refurbished parliamentary office in Accra, capital of Ghana. China'S State Hualong Construction Ghana Limited handed over here on Friday the completed refurbished office structure to Ghana's parliament. (Xinhua/Lin Xiaowei)

In its report presented to parliament on Thursday, the committee said it was convinced that the vaccine approved for clinical trial is safe and that most of the concerns about the vaccine could only be answered after the clinical trials had been undertaken.

Photo taken on Nov. 6, 2015 shows a view of the refurbished parliamentary office in Accra, capital of Ghana. China'S State Hualong Construction Ghana Limited handed over here on Friday the completed refurbished office structure to Ghana's parliament. (Xinhua/Lin Xiaowei)
Photo taken on Nov. 6, 2015 shows a view of the refurbished parliamentary office in Accra, capital of Ghana. China’S State Hualong Construction Ghana Limited handed over here on Friday the completed refurbished office structure to Ghana’s parliament. (Xinhua/Lin Xiaowei)
“Indeed, it is because of these concerns that this scientific exercise is being undertaken with the view of coming out with a cure for the dreaded Ebola Viral Disease,” contained the report signed by Joseph Yieleh Chireh, chairman of the committee, urging the House to adopt the report.

The Ebola pandemic across the world with the epicenter in three countries in West Africa led to over 28,635 cases and over 11,300 deaths as of Nov.8.

Experts say the absence of licensed drugs and vaccines contributed to the impact of the epidemic in the region.
Ghana was selected with four other countries to jointly review two of the candidate vaccines developed by GlaxoSmithKline (GSK) and Crucell BV of Janseen, a subsidiary of Johnson and Johnson.

But, the Ghanaian parliament last June ordered the suspension of the trial over concerns expressed by some civil society organizations and some Members of Parliament that it will end up spreading the virus in Ghana.

After interaction with key stakeholders, the health committee said it was persuaded that there had been no Ebola clinical trials going on in Ghana.

However, the Food and Drugs Authority (FDA) had approved a vaccine, namely the Johnson Ebola vaccine for clinical trials as part of an international effort to find a cure to the EVD.

A second vaccine, the GSK vaccine is currently being considered for approval, the report said adding that the trials were to be conducted with strictest adherence to national regulations and international standards.
The committee recommended to the House to urge the health minister to intensify education on the clinical trials.

Through these trials, Ghana stands at an advantage to develop its own capacity to undertake similar trials on the efficacy of locally manufactured products especially herbal drugs, the report said. Enditem

Source: Xinhua

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.